While disruption of the IFN signaling pathway in melanoma negatively affects tumor response to anti-CTLA-4 therapy [255,256], extensive IFN-γ exposure of melanoma cells increased their resistance to radiotherapy and anti-CTLA-4 treatment [27,257]. Here, CTLA4 is linked to neoplasm.